Series date: 
01/01/2024 - 12:00pm to 12/31/2024 - 1:00pm
COURSE DIRECTOR
Edgardo Rivera, M.D. and Meagan Flummer
 
DESCRIPTION
Current literature reviews pertinent to the case are frequently presented. Clinicopathologic and radiologic correlation with expert presentation is featured. This conference is intended for staff/fellows/residents and medical students interested in the study of cancer.
 
TARGET AUDIENCE
The conference is designed for physicians, residents, fellows, mid-level providers and medical students interested in the study of cancer.
 
LEARNING OBJECTIVES
Upon conclusion of this program, participants should be able to:
  • Describe applicable results of important histology-specific clinical trials.
  • Identify investigational therapeutic regimens that would be alternatives to standard of care approaches.
  • Evaluate current clinical practice approaches and applications to each specific patient.
  • Apply alternative radiology, pathology, and clinical practices.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s)
AMA
The Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Disclosure Summary
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.
 
Listed below are individuals with control of the content of this program who have disclosed…
 
Relevant financial relationship(s) with ineligible companies:
None
 
All relevant financial relationships listed for these individuals have been mitigated. 
 
No relevant financial relationship(s) with ineligible companies:
Edgardo Rivera, M.D.
Janis Pikulin
Meagan Flummer
Tanya McConnell (coordinator)
 
References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None
 
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here

ATTENDANCE/CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance.  All learners are encouraged to text attendance regardless of credit needs.  This number is only used for receiving text messages related to tracking attendance.  Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this series will appear on your Transcript.

QUESTIONS?
Email Tanya McConnell
Support location: 
Arizona

Sessions

Session Date
KRMC Tumor Board May 7 2024 05/07/2024 - 12:00pm to 1:00pm
KRMC Tumor Board May 21 2024 05/21/2024 - 12:00pm to 1:00pm
KRMC Tumor Board June 4th 2024 06/04/2024 - 12:00pm to 1:00pm
KRMC Tumor Board June 18 06/18/2024 - 12:00pm to 1:00pm
KRMC Tumor Board July 2 07/02/2024 - 12:00pm to 1:00pm
KRMC Tumor Board July 16 07/16/2024 - 12:00pm to 1:00pm
KRMC Tumor Board August 6 08/06/2024 - 12:00pm to 1:00pm
KRMC Tumor Board August 20 08/20/2024 - 12:00pm to 1:00pm
KRMC Tumor Board September 3 09/03/2024 - 12:00pm to 1:00pm
KRMC Tumor Board September 17 09/17/2024 - 12:00pm to 1:00pm

Pages